comparemela.com

Latest Breaking News On - Laverty pathology - Page 1 : comparemela.com

HLS ASX: Australian Clinical labs, the No 3 player in Australia s pathology market, withdrew a takeover bid for No 2 player Healius after the ACCC blocked a merger, but has not given up entirely

Australian Clinical Labs, the No.3 player in the pathology market, has not given up in its chase for ailing No.2 player Healius.

Insider Buying: Healius Limited (ASX:HLS) Insider Buys A$80,560 00 in Stock

Healius Limited (ASX:HLS – Get Free Report) insider Kathryn (Kate) McKenzie bought 53,000 shares of Healius stock in a transaction on Monday, December 4th. The stock was acquired at an average cost of A$1.52 ($1.01) per share, with a total value of A$80,560.00 ($53,350.99). Healius Stock Performance The company has a current ratio of 0.55, […]

HLS ASX: Australia s No 2 player in pathology, Healius, faces painful restructuring ahead

Insider Buying: Healius Limited (ASX:HLS) Insider Buys 8,000 Shares of Stock

Insider Buying: Healius Limited (ASX:HLS) Insider Buys 8,000 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Healius Limited (ASX:HLS) Insider Jennifer (Jenny) Macdonald Purchases 8,000 Shares

Healius Limited (ASX:HLS – Get Free Report) insider Jennifer (Jenny) Macdonald acquired 8,000 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were purchased at an average price of A$2.53 ($1.63) per share, with a total value of A$20,232.00 ($13,052.90). Healius Stock Performance The company has a quick ratio of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.